C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2011
10/12/2011	CN102215833A Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
10/12/2011	CN102212137A Genetically engineered recombinant polypeptide for cloven-hoofed animals
10/12/2011	CN102212136A ScFv (single chain variable fragment) antibody used for detecting norfloxacin, and encoding gene and application thereof
10/12/2011	CN102212135A Anti-vascular endothelial growth factor monoclonal antibody and application thereof
10/12/2011	CN102212134A Polyclonal antibody against outer membrane protein of Candidatus liberobacter asiaticum, and preparation method and application thereof
10/12/2011	CN102212133A Fab segment of human-source human immunodeficiency virus (HIV) antibody and coded gene and application thereof
10/12/2011	CN102212132A Binding molecules capable of neutralizing rabies virus and uses thereof
10/12/2011	CN102212131A Binding molecules capable of neutralizing rabies virus and uses thereof
10/12/2011	CN102212130A Separation and purification preparation method for high-flux antiserum
10/12/2011	CN102210852A Treatment of T-cell mediated diseases
10/12/2011	CN101519448B Epididymal protease inhibitor protein monoclonal antibody and application thereof
10/12/2011	CN101139394B Cytoplasma membrane surface antigen monoclonal antibody and uses thereof
10/11/2011	US8035185 Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same
10/11/2011	US8034919 Probe, probe set, probe carrier, and testing method
10/11/2011	US8034918 Probe, probe set, probe carrier, and testing method
10/11/2011	US8034906 Crystalline anti-hTNFalpha antibodies
10/11/2011	US8034904 First therapeutic agent is an antibody or an epitope-binding fragment having the same amino acid sequence as the murine antibody EM164 produced by mouse hybridoma EM164; a second therapeutical agent selected from carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel etc.; anticarcinogenic agents
10/11/2011	US8034903 Degraded TPO agonist antibody
10/11/2011	US8034902 Recombinant antibodies against CD55 and CD59 and uses thereof
10/11/2011	US8034787 Enzyme-cleavable prodrug compounds
10/11/2011	US8034784 Method of suppressing or reducing IL-TIF-induced inflammation, or treating associated conditions thereof, using Zcytor16
10/11/2011	US8034769 Oxidized proteins and oxidized protein inhibitor compositions and methods of use thereof
10/11/2011	US8034762 Treatment of subarachnoid hemorrhage with Apo E analogs
10/11/2011	US8034358 Surface antigen
10/11/2011	US8034352 Tetrameric cytokines with improved biological activity
10/11/2011	US8034351 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034346 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same
10/11/2011	US8034344 Anti-IL-6/IL-6R antibodies and methods of use thereof
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	US8034341 Methods of inhibiting tumor growth using blocking antibodies to IL-23R
10/11/2011	US8034340 Method for treating an immune disorder by decreasing NIK-SIVA complex formation
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	US8034338 Immunogenic recombinant antibody
10/11/2011	US8034337 Interleukin-1α antibodies
10/11/2011	US8034336 Antibodies against a peptide epitope of apoliprotein B
10/11/2011	CA2504938C Compositions and methods for treating or preventing pneumococcal infection
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2458462C Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/11/2011	CA2378584C New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
10/11/2011	CA2362098C Human polyclonal antibodies from genetically engineered animals
10/06/2011	WO2011123826A2 Prevention and treatment of cast nephropathy
10/06/2011	WO2011123708A2 Genetic engineering of non-human animals for the production of chimeric antibodies
10/06/2011	WO2011123507A1 Humanized il-25 antibodies
10/06/2011	WO2011123489A2 Anti-cd40 antibodies
10/06/2011	WO2011123396A1 Compositions and methods for the removal of biofilms
10/06/2011	WO2011123381A1 Antibodies against csf-1r
10/06/2011	WO2011123042A1 Vaccination procedure and products for use therein
10/06/2011	WO2011122550A1 Method of preparing immunogen and method of producing an antibody using same
10/06/2011	WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011	WO2011122011A2 Antibodies with modified affinity to fcrn that promote antigen clearance
10/06/2011	WO2011121556A2 Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)
10/06/2011	WO2011121110A1 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
10/06/2011	WO2011121040A1 Humanized anti cxcr4 antibodies for the treatment of cancer
10/06/2011	WO2011120859A1 Fusion protein and its uses
10/06/2011	WO2011120135A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011120134A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011100620A3 Upar binding agents and methods of use thereof
10/06/2011	WO2011096894A3 Use of novel markers of pluripotent stem cells
10/06/2011	WO2011084255A3 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
10/06/2011	WO2011083090A3 Methods for treating breast cancer
10/06/2011	WO2011071574A3 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
10/06/2011	WO2011054359A3 Method for early detection of cancer using o - glycosylated mucin peptides or corresponding monoclonal antibodies
10/06/2011	WO2011053763A3 Il-17a antagonists
10/06/2011	WO2011041350A9 Xenotropic mulv-related virus (xmrv) compositions and methods of use
10/06/2011	WO2011041319A8 Specific binding proteins and uses thereof
10/06/2011	WO2011029881A3 A method for binding a recombinant polypeptide to a carrier
10/06/2011	WO2010145792A8 Bispecific antigen binding proteins
10/06/2011	US20110245473 Anti-IL-6 Receptor Antibody
10/06/2011	US20110245472 Method for the mass production of immunoglobulin constant region
10/06/2011	US20110245471 NUCLEAR FACTOR kappaB INDUCING FACTOR
10/06/2011	US20110245470 Immunoglobulins
10/06/2011	US20110245469 Intermediates formed in biosynthesis of relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110245468 B7-h5, a costimulatory polypeptide
10/06/2011	US20110245467 Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics Via Consecutive Addition of Quantifiable Extenders
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110244576 Herpes Simplex Virus Complex
10/06/2011	US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators
10/06/2011	US20110244546 Internalizing Anti-CD74 Antibodies and Methods of Use
10/06/2011	US20110244545 Polymeric carriers for immunohistochemistry and in situ hybridization
10/06/2011	US20110244544 Polymeric carriers for immunohistochemistry and in situ hybridization
10/06/2011	US20110244520 Compositions and Methods for Bacterial Production of Chondroitin
10/06/2011	US20110244517 System for antibody expression and assembly
10/06/2011	US20110244516 Rage Fusion Proteins And Methods Of Use
10/06/2011	US20110244514 Mammalian Sweet Taste Receptors
10/06/2011	US20110244513 Isolated mammalian membrane protein genes; related reagents
10/06/2011	US20110244489 Method for the early detection of renal injury
10/06/2011	US20110244485 Anti-tuna vasa antibody
10/06/2011	US20110244483 Assessment of protein degradation by measurement of collagen fragments
10/06/2011	US20110244482 Assessment of subchondral bone remodelling by measuring cathepsin k fragments of collagen type ii
10/06/2011	US20110244475 MN Gene and Protein
10/06/2011	US20110244053 Use a goat serum for veterinary treatment
10/06/2011	US20110244011 Specific delivery of agrochemicals
10/06/2011	US20110243978 Enterococcus antigens
10/06/2011	US20110243966 SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO
10/06/2011	US20110243965 Antibodies against domains of laminin-332
10/06/2011	US20110243963 Antibodies to lrp6
10/06/2011	US20110243962 Therapeutic use of specific ligand in msrv associated diseases

1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 1494